Therapeutic drug monitoring as predictive marker of mucosal healing in Crohn's disease patients treated with anti-TNF: a prospective multi-centre study

被引:0
|
作者
Bertani, L. [1 ]
Bodini, G. [2 ]
Mondello, G. [1 ]
Mumolo, M. G. [3 ]
Maltinti, S. [1 ]
Baldissarro, I. [2 ]
Tapete, G. [1 ]
Albano, E. [1 ]
Ceccarelli, L. [3 ]
Crespi, M. [2 ]
Savarino, V. [2 ]
Marchi, S. [1 ]
Costa, F. [3 ]
机构
[1] Univ Pisa, Dept New Technol & Translat Sci Med & Surg, Pisa, Italy
[2] Univ Genoa, Dept Internal Med, Gastroenterol Unit, Genoa, Italy
[3] Pisa Univ Hosp, Dept Gen Surg & Gastroenterol, Pisa, Italy
来源
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词
D O I
10.1093/ecco-jcc/jjy222.700
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P576
引用
收藏
页码:S402 / S403
页数:3
相关论文
共 50 条
  • [21] HIGHER ANTI-TNFα TROUGH LEVELS ARE ASSOCIATED WITH INCREASED RADIOLOGICAL RESPONSE IN PERIANAL FISTULISING CROHN'S DISEASE: A MULTI-CENTRE STUDY
    Lee, Tanya
    Gilbert, Lauren
    van Langenberg, Daniel R.
    Srinivasan, Ashish
    Lee, Allan
    Martin, Catherine A.
    Yong, Eric
    Ding, Nik S.
    Sparrow, Miles
    GASTROENTEROLOGY, 2020, 158 (06) : S1038 - S1038
  • [22] Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study
    Townsend, T.
    Razanskaite, V.
    Michail, S.
    Morgan, J.
    Davies, M.
    Storey, D.
    Watters, C.
    Penman, D.
    Swaminathan, M.
    Sabine, J.
    Chapman, A.
    Vyas, A.
    Reilly, I.
    Flanagan, P.
    Bodger, K.
    Subramanian, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S407 - S408
  • [23] Definition of therapeutic response criteria using MRI in Crohn's disease patients treated with anti-TNF therapy: a multicenter prospective study (the IRMA study)
    Buisson, A.
    Messadeg, L.
    Bouguen, G.
    Goutorbe, F.
    Reimund, J. -M.
    Goutte, M.
    Sautel, C.
    Duron, C.
    Scanzi, J.
    Reymond, M.
    Allimant, C.
    Dapoigny, M.
    Bommelaer, G.
    Pereira, B.
    Hordonneau, C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S33 - S33
  • [24] DEFINITION OF THERAPEUTIC RESPONSE CRITERIA USING MRI IN CROHN'S DISEASE PATIENTS TREATED WITH ANTI-TNF THERAPY: A MULTICENTER PROSPECTIVE STUDY (THE IRMA STUDY)
    Buisson, Anthony
    Messadeg, Leila
    Bouguen, Guillaume
    Goutorbe, Felix
    Reimund, Jean-Marie
    Goutte, Marion
    Sautel, Camille
    Boucher, Anne-Laure
    Scanzi, Julien
    Duron, CDric
    Dapoigny, Michel
    Bommelaer, Gilles
    Pereira, Bruno
    Hordonneau, Constance
    GASTROENTEROLOGY, 2017, 152 (05) : S384 - S384
  • [25] 6-Thioguanine nucleotide levels are associated with mucosal healing in patients with Crohn's disease: A multi-centre, international study
    Mao, R.
    Guo, J.
    Luber, R.
    Chen, B. -L.
    He, Y.
    Zeng, Z. -R.
    Ben-Horin, S.
    Sparrow, M.
    Xavier, R.
    Chen, M. -H.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S385 - S385
  • [26] Advances in optimalisation of therapeutic drug monitoring using mucosal TNF expression and anti-TNF concentration in patients with inflammatory bowel disease treated with biologicals: Preliminary results from a single-centre study
    Farkas, K.
    Elekes, G.
    Kata, D.
    Foeldesi, I.
    Lada, S.
    Ferenci, T.
    Madacsy, T.
    Rutka, M.
    Balint, A.
    Bor, R.
    Fabian, A.
    Milassin, A.
    Szepes, Z.
    Nagy, F.
    Maleth, J.
    Molnar, T.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S441 - S442
  • [27] Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies
    Eder, Piotr
    Stawczyk-Eder, Kamila
    Korybalska, Katarzyna
    Czepulis, Natasza
    Luczak, Joanna
    Lykowska-Szuber, Liliana
    Krela-Kazmierczak, Iwona
    Linke, Krzysztof
    Witowski, Janusz
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (01) : 135 - 140
  • [28] Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies
    Piotr Eder
    Kamila Stawczyk-Eder
    Katarzyna Korybalska
    Natasza Czepulis
    Joanna Luczak
    Liliana Lykowska-Szuber
    Iwona Krela-Kazmierczak
    Krzysztof Linke
    Janusz Witowski
    World Journal of Gastroenterology, 2017, (01) : 135 - 140
  • [29] REASSESSMENT OF CROHN'S DISEASE TREATED WITH 12 MONTHS OF ANTI-TNF THERAPY: A TERTIARY CENTRE EXPERIENCE
    Dart, R.
    Griffin, N.
    Taylor, K.
    Duncan, J.
    Sastrillo, M.
    Anderson, S.
    Sanderson, J.
    Irving, P. M.
    GUT, 2012, 61 : A397 - A397
  • [30] Maintenance-phase serum anti-TNF levels are not associated with mucosal healing in pediatric Crohn's disease
    Grabovski, Rinat
    Regev, Stave
    Matar, Manar
    Weintraub, Yael
    Shamir, Raanan
    Shouval, Dror S.
    Tal, Noa
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2025,